Advocacy Alert: Canadian patent system makes it harder for those who invest in research and development to enjoy the fruits of their innovation (Supreme Court Appeal): Register today for your Conference Call briefing June 03
May 25, 2009

Ottawa, May 25, 2009…CATAAlliance has filed an Affidavit in the Supreme Court of Canada regarding the Lilly v. Apotex decisions of the Federal Court and Federal Court of Appeal (File Nos. T-1364-05 and A-84-08), expressing the industry’s concern over aspects of Canada’s patent system. 

According to CATA President John Reid, “If Canada follows its own standard regarding the contents of patent applications, and then Canada is putting itself in a questionable position, making it harder for those who invest in research and development to enjoy the fruits of their innovation in this country.” 
 

CATAAlliance is known for its Innovation Nation Campaign: Canada's lack of innovation, a 13th place ranking or a D Grade in Innovation, among the 17 OECD nations, is leading to mediocre socio-economic performance compared to other developed countries (Conference Board of Canada).  

Reid concluded, “The mission of our Innovation Nation Campaign is to move Canada from 13th to 1st place or an A grade in Innovation. Having a non competitive patent system does not move us in the right direction.”

++ Action Item:
To register for your Conference Call Briefing on Wednesday, June 03, beginning at 11 am to noon,  please send an email to Emily Boucher at eboucher@cata.ca with Patent Systems in the subject line. We will then send you your local call in number and access code will be sent to you via email. Note that the Call-in Registration fee is complimentary for CATA members and $45 (plus gst) for Non Members. Callers will be provided with a copy of the Affidavit and also have access to legal counsel for a Q&A.